Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Molnar

Showing results (61-70 of 130) with videos related to

Pageof 13
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 2, 1999
Use of carrier cells to deliver a replication-selective herpes simplex virus-1 mutant for the intraperitoneal therapy of epithelial ovarian cancerG Coukos, A Makrigiannakis, E H Kang, et al.
Biochemical and Biophysical Research Communications|August 30, 1994
A putative sirolimus (rapamycin) effector proteinY Chen, H Chen, A E Rhoad, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|September 21, 2007
Utilization of recombinant activated factor VII in southern Ontario in 85 patients with and without haemophiliaK E Webert, D M Arnold, J Carruthers, et al.
Virology|April 1, 1990
High level expression of the envelope glycoproteins of the human immunodeficiency virus type I in presence of rev gene using helper-independent adenovirus type 7 recombinantsP K Chanda, R J Natuk, B B Mason, et al.
Natural Immunity and Cell Growth Regulation|January 1, 1990
Adenovirus vaccine strains genetically engineered to express HIV-1 or HBV antigens for use as live recombinant vaccinesP P Hung, P K Chanda, R J Natuk, et al.
Human Gene Therapy|October 6, 1998
Impact of preexisting and induced humoral and cellular immune responses in an adenovirus-based gene therapy phase I clinical trial for localized mesotheliomaK L Molnar-Kimber, D H Sterman, M Chang, et al.
Natural Immunity and Cell Growth Regulation|January 1, 1988
Expression of HBV surface antigen or HIV envelope protein using recombinant adenovirus vectorsP P Hung, J E Morin, M D Lubeck, et al.
Journal of Virology|November 23, 2000
Combination therapy with lamivudine and adenovirus causes transient suppression of chronic woodchuck hepatitis virus infectionsT Zhou, J T Guo, F A Nunes, et al.
Cancer Research|February 1, 1997
Use of a "replication-restricted" herpes virus to treat experimental human malignant mesotheliomaJ C Kucharczuk, B Randazzo, M Y Chang, et al.
European Journal of Anaesthesiology|May 2, 2017
Management of severe perioperative bleeding: guidelines from the European Society of Anaesthesiology: First update 2016Sibylle A Kozek-Langenecker, Aamer B Ahmed, Arash Afshari, et al.
Pageof 13

Showing results (61-70 of 130) with videos related to

Sort By:
Pageof 13
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 2, 1999
Use of carrier cells to deliver a replication-selective herpes simplex virus-1 mutant for the intraperitoneal therapy of epithelial ovarian cancerG Coukos, A Makrigiannakis, E H Kang, et al.
Biochemical and Biophysical Research Communications|August 30, 1994
A putative sirolimus (rapamycin) effector proteinY Chen, H Chen, A E Rhoad, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|September 21, 2007
Utilization of recombinant activated factor VII in southern Ontario in 85 patients with and without haemophiliaK E Webert, D M Arnold, J Carruthers, et al.
Virology|April 1, 1990
High level expression of the envelope glycoproteins of the human immunodeficiency virus type I in presence of rev gene using helper-independent adenovirus type 7 recombinantsP K Chanda, R J Natuk, B B Mason, et al.
Natural Immunity and Cell Growth Regulation|January 1, 1990
Adenovirus vaccine strains genetically engineered to express HIV-1 or HBV antigens for use as live recombinant vaccinesP P Hung, P K Chanda, R J Natuk, et al.
Human Gene Therapy|October 6, 1998
Impact of preexisting and induced humoral and cellular immune responses in an adenovirus-based gene therapy phase I clinical trial for localized mesotheliomaK L Molnar-Kimber, D H Sterman, M Chang, et al.
Natural Immunity and Cell Growth Regulation|January 1, 1988
Expression of HBV surface antigen or HIV envelope protein using recombinant adenovirus vectorsP P Hung, J E Morin, M D Lubeck, et al.
Journal of Virology|November 23, 2000
Combination therapy with lamivudine and adenovirus causes transient suppression of chronic woodchuck hepatitis virus infectionsT Zhou, J T Guo, F A Nunes, et al.
Cancer Research|February 1, 1997
Use of a "replication-restricted" herpes virus to treat experimental human malignant mesotheliomaJ C Kucharczuk, B Randazzo, M Y Chang, et al.
European Journal of Anaesthesiology|May 2, 2017
Management of severe perioperative bleeding: guidelines from the European Society of Anaesthesiology: First update 2016Sibylle A Kozek-Langenecker, Aamer B Ahmed, Arash Afshari, et al.
Pageof 13